| abstract |
The present invention provides a compound of formula (I) as further described in the specification: Of the triazole compound. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I) and a method of treating a disorder mediated by at least in part KSP in a mammalian patient, wherein the mammal is in need of such treatment. Also provided is a method comprising administering to a patient a therapeutically effective amount of a compound of formula (I). |